HRAS and urinary bladder carcinoma: Common mutations in bladder cancer include TP53, PIK3CA, TSC1, FGFR3, HRAS, and HER2. Moreover, common abnormal expression genes include EGFR, Ki67, PD-L1, ERCC1, and BRCA1. Shariat et al.